Wilson Wu

952 total citations · 1 hit paper
16 papers, 393 citations indexed

About

Wilson Wu is a scholar working on Molecular Biology, Oncology and Hepatology. According to data from OpenAlex, Wilson Wu has authored 16 papers receiving a total of 393 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 6 papers in Oncology and 5 papers in Hepatology. Recurrent topics in Wilson Wu's work include Hepatocellular Carcinoma Treatment and Prognosis (5 papers), Pancreatic and Hepatic Oncology Research (4 papers) and Angiogenesis and VEGF in Cancer (3 papers). Wilson Wu is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (5 papers), Pancreatic and Hepatic Oncology Research (4 papers) and Angiogenesis and VEGF in Cancer (3 papers). Wilson Wu collaborates with scholars based in United States, South Africa and Taiwan. Wilson Wu's co-authors include William Proctor Harris, Nathan Bahary, Mark M. Zalupski, Lei Zheng, Tara Elisabeth Seery, Jie Pu, Carrie Aldrich, Fadi Braiteh, Darren Sigal and Andrea J. Bullock and has published in prestigious journals such as Journal of Clinical Oncology, Annals of Oncology and Optics Express.

In The Last Decade

Wilson Wu

12 papers receiving 390 citations

Hit Papers

HALO 202: Randomized Phase II Study of PEGPH20 Plus Nab-P... 2017 2026 2020 2023 2017 100 200 300
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. HALO 202: Randomized Phase II Study of PEGPH20 Plus Nab-Paclitaxel/Gemcitabine Versus Nab-Paclitaxel/Gemcitabine in Patients With Untreated, Metastatic Pancreatic Ductal Adenocarcinoma
    2017 365 citations Sunil R. Hingorani, Lei Zheng et al. Journal of Clinical Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Wilson Wu United States 5 320 114 105 85 47 16 393
Dimitrios Chondros United States 4 333 1.0× 117 1.0× 110 1.0× 87 1.0× 48 1.0× 9 399
Jie Pu United States 4 356 1.1× 122 1.1× 111 1.1× 88 1.0× 60 1.3× 10 422
Valentina Poltavets Australia 4 202 0.6× 86 0.8× 87 0.8× 148 1.7× 76 1.6× 6 375
Frank P. Assen Austria 5 210 0.7× 76 0.7× 132 1.3× 124 1.5× 34 0.7× 5 436
Kendelle J. Murphy Australia 8 204 0.6× 72 0.6× 69 0.7× 142 1.7× 51 1.1× 12 324
Prabhu Arumugam United Kingdom 9 292 0.9× 99 0.9× 73 0.7× 132 1.6× 26 0.6× 11 386
Priska Auf der Maur Switzerland 5 240 0.8× 96 0.8× 174 1.7× 160 1.9× 27 0.6× 6 412
Mary Topalovski United States 5 194 0.6× 82 0.7× 122 1.2× 117 1.4× 30 0.6× 5 341
Majdi Maiel France 2 226 0.7× 89 0.8× 78 0.7× 189 2.2× 66 1.4× 2 372
Chanthirika Ragulan United Kingdom 5 327 1.0× 90 0.8× 149 1.4× 134 1.6× 19 0.4× 11 414

Countries citing papers authored by Wilson Wu

Since Specialization
Citations

This map shows the geographic impact of Wilson Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wilson Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wilson Wu more than expected).

Fields of papers citing papers by Wilson Wu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wilson Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wilson Wu. The network helps show where Wilson Wu may publish in the future.

Co-authorship network of co-authors of Wilson Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Wilson Wu. A scholar is included among the top collaborators of Wilson Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wilson Wu. Wilson Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Wu, Wilson, Aleš Leonardis, Jianbo Jiao, Jun Jiang, & Linjiang Chen. (2025). Transformer-Based Models for Predicting Molecular Structures from Infrared Spectra Using Patch-Based Self-Attention. The Journal of Physical Chemistry A. 129(8). 2077–2085. 4 indexed citations
2.
Wu, Wilson, et al.. (2025). Feasibility study of frequency-encoded photonic qubits over a free-space channel. Optics Express. 33(19). 40437–40437.
3.
Wu, Wilson, et al.. (2025). Towards fully passive time-bin quantum key distribution over moving free-space channels. Optics Express. 33(17). 35635–35635.
4.
Wainberg, Zev A., Gulam A. Manji, Nathan Bahary, et al.. (2024). ARC-8: Phase 1/1b randomized study of quemliclustat + gemcitabine/nab-paclitaxel ± zimberelimab in patients with treatment-naive metastatic pancreatic adenocarcinoma.. Journal of Clinical Oncology. 42(3_suppl). 665–665. 3 indexed citations
5.
Song, Yun S., et al.. (2024). Ultrafast classical phylogenetic method beats large protein language models on variant effect prediction. PubMed. 37. 130265–130290. 2 indexed citations
6.
Hekman, Ryan, et al.. (2021). Egg Case Protein 3: A Constituent of Black Widow Spider Tubuliform Silk. Molecules. 26(16). 5088–5088. 4 indexed citations
7.
Hingorani, Sunil R., Lei Zheng, Andrea J. Bullock, et al.. (2017). HALO 202: Randomized Phase II Study of PEGPH20 Plus Nab-Paclitaxel/Gemcitabine Versus Nab-Paclitaxel/Gemcitabine in Patients With Untreated, Metastatic Pancreatic Ductal Adenocarcinoma. Journal of Clinical Oncology. 36(4). 359–366. 365 indexed citations breakdown →
8.
Hingorani, Sunil R., Andrea J. Bullock, Tara Elisabeth Seery, et al.. (2017). Randomized phase 2 study of PEGPH20 Plus nab-paclitaxel/gemcitabine (PAG) vs AG in patients (Pts) with untreated, metastatic pancreatic ductal adenocarcinoma (mPDA). Annals of Oncology. 28. v261–v261. 4 indexed citations
9.
Hingorani, Sunil R., Andrea J. Bullock, Tara Elisabeth Seery, et al.. (2017). PEGPH20 improves pfs in patients with metastatic pancreatic ductal adenocarcinoma: A randomized phase 2 study in combination with nab-paclitaxel/gemcitabine. Annals of Oncology. 28. iii137–iii138. 5 indexed citations
10.
11.
12.
13.
14.
Dou, Sen, Wilson Wu, Annabelle Pratt, & P. Vijay Kumar. (2006). DC Transformer with Line Frequency Ripple Cancellation. 2006 5th International Power Electronics and Motion Control Conference. 1–5.
15.
Lin, Jian‐Wei, et al.. (2006). A Web-based Environmental Experiment System Using Microsoft .NET and COM. Conference proceedings - IEEE Instrumentation/Measurement Technology Conference. 51. 1558–1563. 1 indexed citations
16.
Wu, Wilson, et al.. (2006). DC Transformer with Line Frequency Ripple Cancellation. 1–5. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Dimitrios Chondros Breakdown of academic impact, for papers by Jie Pu Breakdown of academic impact, for papers by Valentina Poltavets Breakdown of academic impact, for papers by Frank P. Assen Breakdown of academic impact, for papers by Kendelle J. Murphy Breakdown of academic impact, for papers by Prabhu Arumugam Breakdown of academic impact, for papers by Priska Auf der Maur Breakdown of academic impact, for papers by Mary Topalovski Breakdown of academic impact, for papers by Majdi Maiel Breakdown of academic impact, for papers by Chanthirika Ragulan
Rankless by CCL
2026